Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of...